ERNESTO GRENIER: Open Payments
NPI 1366614927 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 33 payments from 8 companies in 2025. Trend: 2023 $1,514 · 2024 $881 · 2025 $910
Food & beverage: $806Education: $104
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $352 |
| Otsuka America Pharmaceutical, Inc. | 6 | $243 |
| ABBVIE INC. | 3 | $82 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $65 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Alkermes, Inc. | 1 | $15 |
Products named: ABILIFY MAINTENA, UZEDY, VRAYLAR, AUSTEDO XR, COBENFY, FANAPT, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
